Every business or industry strives to improve quality, reduce costs and improve their products time to market. This, surprisingly, is true for the biotechnology industry as well. Usually regulations increase costs and create hurdles for these companies, but in the...
Cirius Therapeutics announced today that positive results from an interim analysis of exploratory endpoints from the EMMINENCE trial, its ongoing Phase 2b clinical trial evaluating MSDC-0602K in 402 patients diagnosed with non-alcoholic steatohepatitis (NASH) with...
Billing and reimbursement are key to the bottom line success of trials. Optimize the reimbursement with best practices. Clinical Trial Billing Documentation Best Practices: Optimize Reimbursement **A CenterWatch Webinar** Wednesday, April 24, 2019, 11:00 a.m. –...
GlycoMimetics, Inc. (NASDAQ: GLYC) today announced plans to initiate a clinical trial of GMI-1359 in breast cancer patients whose tumors have spread to bone. GMI-1359 is a dual function antagonist that targets both E-selectin and CXCR4, both of which are involved in...
Pivotal Phase 3 study is evaluating efficacy and safety of investigational regenerative skin tissue in adults with deep partial-thickness burns Mallinckrodt plc(NYSE: MNK), a leading global specialty pharmaceutical company, today announced that Stratatech,...
Innoplexus leveraged a proprietary domain-specific AI based model trained on millions of data points to assess Biogen’s Alzheimer’s drug On March 21st, 2019, Biogen’s stock declined sharply, showing a decrease of 29%, resulting in losses to the tune...
Email
Text